Chemical manufacturer
FDA over the counter drug approval process. Comprehensive tax reform; global competitiveness for U.S. businesses; extending R&D tax credits; CFC look-through provision; duty suspension.
MED - Medical/Disease Research/Clinical Labs TAX - Taxation/Internal Revenue Code
135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
HOLLAND & KNIGHT LLP
800 17th Street NW, Suite 1100, Washington, DC, 20006, US
JOEL ROBERSON MICHAEL WERNER KERRY FEEHERY RICHARD M GOLD RICHARD M GOLD KERRY FEEHERY KATHRYN H LEHMAN